Skip to main content
GutCited

Lactobacillus acidophilus 관련 Irritable Bowel Syndrome (IBS)

B

Improves intestinal transit time and reduces constipation symptoms in IBS-C. Fecal pH decreases indicating improved fermentation. Best evidence for L. acidophilus NCFM strain.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dlactobacillus\u002Dacidophilus\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

결론

Improves intestinal transit time and reduces constipation symptoms in IBS-C. Fecal pH decreases indicating improved fermentation. Best evidence for L. acidophilus NCFM strain.

Key Study Findings

Randomized Controlled Trial n=200 12 weeks Double-blind
Probiotic Blend of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis ssp. Lactis BB-12 in Non-constipated Irritable …
Dose: None vs: placebo Outcome: IBS-Global Improvement Scale response 효과: 19.3% vs 8.9% response at day 28 p=0.048

대상 집단: adults with non-constipated irritable bowel syndrome

Meta-Analysis n=3154
Comparative effectiveness and safety of probiotics with psychotropic potential in mental health benefits in irritable …
Dose: None vs: placebo Outcome: quality of life, depression, and anxiety in IBS … 효과: SUCRA=89.7% (B. longum for QoL); SUCRA=95.6% (probiotic combo for depression) None

대상 집단: patients with irritable bowel syndrome

Randomized Controlled Trial n=61 12 weeks Double-blind
Four-strain probiotic exerts a positive effect on irritable bowel syndrome symptoms occurring in inflammatory bowel …
Dose: None vs: Placebo Outcome: IBS-SSS (100-point reduction) 효과: 45% active vs 33% placebo (P=0.42) P=0.42

대상 집단: IBD patients with IBS symptoms in remission

Randomized Controlled Trial n=110 12 weeks Double-blind
A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for …
Dose: 10^9 CFU L. acidophilus LA-5 + L. paracasei daily vs: Placebo cultured milk Outcome: Depression risk and serotonin levels in IBS patients 효과: None <0.001 (depression score)

대상 집단: IBS patients with normal mood and subthreshold depression

In Vitro
Bowel Inflammation and Nutrient Supplementation: Effects of a Fixed Combination of Probiotics, Vitamins, and Herbal …
Dose: None vs: None Outcome: Colitis severity 효과: None None

대상 집단: Crohn's disease patients

Randomized Controlled Trial 4 weeks
Efficacy of Quadruple-coated Probiotics in Patients With Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled, Parallel-group …
Dose: 2 g vs: Placebo Outcome: Constipation symptoms 효과: None P = 0.005

대상 집단: IBS patients

Key Statistics

3

연구

350

참여자

Positive

B

등급

Referenced Papers

Diseases (Basel, Switzerland) 2018 50 인용
Alimentary pharmacology & … 2010 4 인용
Neurogastroenterology and motility 2009 81 인용
Minerva gastroenterologica e … 2006 22 인용
Journal of clinical … 2004 298 인용
Journal of clinical … 2004 205 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
1-10 billion CFU/day
ibssupport:
10 billion CFU/day for 4-8 weeks
lactosesupport:
1-2 billion CFU with dairy consumption

상한량: Generally well-tolerated up to 20 billion CFU/day

연구에서 사용된 용량

용량 기간 효과 N
None 12 weeks Positive 200
None -- Positive 3154
None 12 weeks Neutral 61
10^9 CFU L. acidophilus LA-5 + L. paracasei daily 12 weeks Positive 110
None -- Positive --
2 g 4 weeks Mixed --
Chitin-glucan + L. acidophilus NCFM 9 weeks Positive --
None -- Neutral --

권장 복용 시간: On an empty stomach or before meals; may also be taken with dairy

Safety & Side Effects

보고된 부작용

  • Mild gas and bloating during initial use
  • Occasional loose stools
  • Rare allergic reactions in dairy-sensitive individuals (dairy-cultured strains)
  • Very rare: bacteremia in immunocompromised individuals

알려진 상호작용

  • Antibiotics (may reduce probiotic viability; space dosing 2 hours apart)
  • Immunosuppressants (theoretical risk in immunocompromised patients)
  • Sulfasalazine (may affect bacterial metabolism)

일일 최대 섭취 허용량: Generally well-tolerated up to 20 billion CFU/day

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Lactobacillus acidophilus help with Irritable Bowel Syndrome (IBS)?
Based on 3 studies with 350 participants, there is moderate evidence from clinical studies that Lactobacillus acidophilus may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).
How much Lactobacillus acidophilus should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 1-10 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Lactobacillus acidophilus?
Reported side effects may include Mild gas and bloating during initial use, Occasional loose stools, Rare allergic reactions in dairy-sensitive individuals (dairy-cultured strains), Very rare: bacteremia in immunocompromised individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Lactobacillus acidophilus and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 3 peer-reviewed studies with 350 total participants. The overall direction of effect is positive.

Related Evidence

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.